Back to top

stock-price-movement: Archive

Zacks Equity Research

All You Need to Know About DHI Group (DHX) Rating Upgrade to Buy

DHI Group (DHX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DHXNegative Net Change

Zacks Equity Research

Viavi Solutions (VIAV) Upgraded to Strong Buy: Here's Why

Viavi Solutions (VIAV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

VIAVPositive Net Change

Zacks Equity Research

Atlanticus (ATLC) Upgraded to Buy: Here's What You Should Know

Atlanticus (ATLC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

ATLCPositive Net Change

Zacks Equity Research

What Makes Adherex Technologies (FENC) a New Strong Buy Stock

Adherex Technologies (FENC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

FENCPositive Net Change

Zacks Equity Research

All You Need to Know About Paysign (PAYS) Rating Upgrade to Buy

Paysign (PAYS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PAYSPositive Net Change

Zacks Equity Research

Here's Why InflaRx (IFRX) Is a Great 'Buy the Bottom' Stock Now

InflaRx (IFRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

IFRXNegative Net Change

Zacks Equity Research

After Plunging 31.2% in 4 Weeks, Here's Why the Trend Might Reverse for SKYX PLATFORMS (SKYX)

SKYX PLATFORMS (SKYX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

SKYXNegative Net Change

Zacks Equity Research

Down 28.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Petrobras (PBR)

Petrobras (PBR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PBRPositive Net Change

Zacks Equity Research

Down 49.7% in 4 Weeks, Here's Why Coherus Oncology (CHRS) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Coherus Oncology (CHRS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CHRSNegative Net Change

Zacks Equity Research

Down 39.2% in 4 Weeks, Here's Why Paysign (PAYS) Looks Ripe for a Turnaround

Paysign (PAYS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

PAYSPositive Net Change